First Time Loading...

Seikagaku Corp
TSE:4548

Watchlist Manager
Seikagaku Corp Logo
Seikagaku Corp
TSE:4548
Watchlist
Price: 740 JPY -0.4% Market Closed
Updated: May 9, 2024
Section:
 

Relative Value

The Relative Value of one Seikagaku Corp stock under the Base Case scenario is 595.07 JPY. Compared to the current market price of 740 JPY, Seikagaku Corp is Overvalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
595.07 JPY
Overvaluation 20%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.2
P/S
P/S
Price to Sales
1.2
vs History
98
vs Industry
68
Median 3Y
1.4
Median 5Y
1.6
Industry
2.5
Forward
1.1
More Details
30.8
P/E
P/E
Price to Earnings
30.8
vs History
25
vs Industry
16
Median 3Y
19.8
Median 5Y
19.8
Industry
23.4
Forward
15.4
More Details
49.6
P/OCF
P/OCF
Price to OCF
49.6
vs History
12
vs Industry
8
Median 3Y
29.4
Median 5Y
20.5
Industry
17.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-18.7
Median 5Y
7.6
Industry
23.6
More Details
0.6
P/B
P/B
Price to Book Value
0.6
vs History
98
vs Industry
73
Median 3Y
0.7
Median 5Y
0.8
Industry
2.1
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
73
vs Industry
83
Median 3Y
0.6
Median 5Y
0.7
Industry
2.6
Forward
0.5
More Details
1.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.1
vs History
66
vs Industry
81
Median 3Y
1.1
Median 5Y
1.2
Industry
5.2
More Details
7.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.4
vs History
49
vs Industry
41
Median 3Y
5.6
Median 5Y
7.4
Industry
13.7
Forward
5.8
More Details
18
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18
vs History
33
vs Industry
26
Median 3Y
9.7
Median 5Y
12.8
Industry
17.2
More Details
22.9
EV/OCF
EV/OCF
Enterprise Value to OCF
22.9
vs History
19
vs Industry
21
Median 3Y
11.1
Median 5Y
9
Industry
16.2
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-9
Median 5Y
2.6
Industry
17.8
More Details
0.3
EV/IC
EV/IC
Enterprise Value to IC
0.3
vs History
90
vs Industry
80
Median 3Y
0.4
Median 5Y
0.6
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Seikagaku Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Seikagaku Corp
TSE:4548
40.4B JPY 1.2 30.8 7.4 18
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
739.8B USD 20.6 120.5 59 67.1
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 16.1 44.1 33 36.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
358.6B USD 4.2 9.3 11.5 15
US
Merck & Co Inc
NYSE:MRK
328.3B USD 5.3 142.4 35.5 57.9
UK
AstraZeneca PLC
LSE:AZN
190.1B GBP 5 37.5 174.3 278.1
CH
Roche Holding AG
SIX:ROG
177.1B CHF 3 15.4 8.8 10.4
CH
Novartis AG
SIX:NOVN
177.1B CHF 3.3 11.1 8.5 12.4
US
Pfizer Inc
NYSE:PFE
158.9B USD 2.9 -514.2 12.8 20.3
P/E Multiple
Earnings Growth
JP
Seikagaku Corp
TSE:4548
Average P/E: 51.4
30.8
22%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
120.5
346%
DK
Novo Nordisk A/S
CSE:NOVO B
44.1
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.3
-20%
US
Merck & Co Inc
NYSE:MRK
142.4
7 454%
UK
AstraZeneca PLC
LSE:AZN
37.5
168%
CH
Roche Holding AG
SIX:ROG
15.4
26%
CH
Novartis AG
SIX:NOVN
11.1
15%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -514.2
680%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.